Advertisement

  • Survivor Profile

    Breaking Down Barriers

    Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.

    by Bradley Jones

  • More Data on COVID-19 Vaccination and Cancer

    Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

    by Anna Goshua

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Searching the Blood for Signs of Altered Immunity

    The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

    by Kate Yandell

  • A Drive for Diversity

    African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

    by Jon Kelvey

  • Forward Look

    Watch Your Mouth

    Dental screening before treatment could stave off dental emergencies.

    by Nancy Averett

  • Q&A

    The Lost Poetry of Patient Stories

    Medical histories capture a vital snapshot of a patient’s health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative.

    by Marci A. Landsmann

  • Keeping CLL in Check

    With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease.

    by Kendall K. Morgan

  • Get Involved

    Filling a Void

    A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.

    by Elizabeth Rosto Sitko

  • Despite Generic Imatinib, Cost of Treating CML Remains High

    The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.

    by Anna Azvolinsky

Advertisement
Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR